LENSAR, INC. Earnings Per Share (Basic)
LENSAR, INC. (LNSR) reported Earnings Per Share (Basic) of $0.14 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- LENSAR, INC. earnings per share, basic for the quarter ending 2026-06-30 was $0.14.
- LENSAR, INC. earnings per share, basic for the quarter ending 2026-03-31 was $1.56.
- LENSAR, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.12.
- LENSAR, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.31.
- LENSAR, INC. earnings per share, basic for fiscal 2025 was -$2.87.
- LENSAR, INC. earnings per share, basic for fiscal 2024 was -$2.73.
- LENSAR, INC. earnings per share, basic for fiscal 2023 was -$1.31.
- LENSAR, INC. earnings per share, basic for fiscal 2022 was -$1.96.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.14 10-Q · filed 2026-08-13 | $1.62 10-Q · filed 2026-08-13 | $1.58 derived: net income ÷ weighted average shares · filed 2026-08-13 | $1.28 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2026-03-31 | $1.56 10-Q · filed 2026-05-08 | $1.44 derived: net income ÷ weighted average shares · filed 2026-05-08 | $1.14 derived: net income ÷ weighted average shares · filed 2026-05-08 | $0.99 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.87 10-K · filed 2026-03-31 |
| 2025-09-30 | -$0.31 10-Q · filed 2025-11-06 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.75 10-Q · filed 2025-11-06 | -$4.35 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-06-30 | -$0.15 10-Q · filed 2026-08-13 | -$2.46 10-Q · filed 2026-08-13 | -$4.06 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$4.20 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-03-31 | -$2.32 10-Q · filed 2026-05-08 | -$3.94 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$4.07 derived: net income ÷ weighted average shares · filed 2026-05-08 | -$4.87 derived: net income ÷ weighted average shares · filed 2026-05-08 |
| 2024-12-31 | -$1.61 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.74 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$2.53 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$2.73 10-K · filed 2026-03-31 |
| 2024-09-30 | -$0.13 10-Q · filed 2025-11-06 | -$0.91 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$1.11 10-Q · filed 2025-11-06 | -$1.46 derived: net income ÷ weighted average shares · filed 2025-11-06 |
| 2024-06-30 | -$0.79 10-Q · filed 2025-08-07 | -$0.98 10-Q · filed 2025-08-07 | -$1.33 derived: net income ÷ weighted average shares · filed 2025-08-07 | -$1.21 derived: net income ÷ weighted average shares · filed 2025-08-07 |
| 2024-03-31 | -$0.19 10-Q · filed 2025-05-08 | -$0.54 derived: net income ÷ weighted average shares · filed 2025-05-08 | -$0.41 derived: net income ÷ weighted average shares · filed 2025-05-08 | -$1.20 derived: net income ÷ weighted average shares · filed 2025-05-08 |
| 2023-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$0.22 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$1.02 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$1.31 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.13 10-Q · filed 2024-11-07 | -$0.67 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.96 10-Q · filed 2024-11-07 | -$1.31 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2023-06-30 | -$0.81 10-Q · filed 2024-08-08 | -$1.21 10-Q · filed 2024-08-08 | -$1.46 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$1.85 derived: net income ÷ weighted average shares · filed 2024-08-08 |
| 2023-03-31 | -$0.40 10-Q · filed 2024-05-09 | -$0.64 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$1.03 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$1.69 derived: net income ÷ weighted average shares · filed 2024-05-09 |
| 2022-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2024-03-04 | -$0.63 derived: net income ÷ weighted average shares · filed 2024-03-04 | -$1.30 derived: net income ÷ weighted average shares · filed 2024-03-04 | -$1.96 10-K · filed 2024-03-04 |
| 2022-09-30 | -$0.39 10-Q · filed 2023-11-09 | -$1.06 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.73 10-Q · filed 2023-11-09 | -$2.14 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-06-30 | -$0.67 10-Q · filed 2023-08-09 | -$1.34 10-Q · filed 2023-08-09 | -$1.76 derived: net income ÷ weighted average shares · filed 2023-08-09 | -$2.41 derived: net income ÷ weighted average shares · filed 2023-08-09 |
| 2022-03-31 | -$0.67 10-Q · filed 2023-05-15 | -$1.08 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$1.73 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$2.20 derived: net income ÷ weighted average shares · filed 2023-05-15 |
| 2021-12-31 | -$0.41 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.06 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.53 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$2.09 10-K · filed 2023-03-16 |
| 2021-09-30 | -$0.65 10-Q · filed 2022-11-09 | -$1.12 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.69 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$0.47 10-Q · filed 2022-08-08 | -$1.03 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |